Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"
NCT03209492
·
clinicaltrials.gov ↗
COMPLETED
Status
333
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Leuprorelin acetate
Sponsor
Takeda